Detailansicht

Wissensnetz

Person

Stefan Schönland (1969-)

Arzt

Name	Stefan Schönland
Zeit	1969- (Lebensdaten)
Ort	Heidelberg (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Priv-Doz. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	Stefan Schoenland Stefan O. Schönland Stefan Olaf Schönland Stefan Schonland S. Schönland S. O. Schönland Stefan Schonland (irrtümliche Namensform) Stefan O. Schonland (irrtümliche Namensform)
Beziehung	Klinikum Heidelberg
Weitere Angaben	Diss. Medizinische Fakultät; Oberarzt Amyloidose- und allogene KMT Ambulanz / KMT Station, Sprecher des interdisziplinären Amyloidosezentrums am Universitätsklinikum Heidelberg, Facharzt für Innere Medizin mit Schwerpunkt Hämatologie und internistische Onkologie
Datensatztyp	Person
GND-Nummer	122405226
Datensatz-ID	122405226
Beteiligt an alle anzeigen Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT Biological and clinical impact of the immunoglobulin light chain sequence diversity in patients with dominant heart AL amyloidosis In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients over 60 years of age: a prospective phase II study Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group P957: Carfilzomib, lenalidomide, dexamethasone followed by a second auto-HCT is an effective strategy in first relapse multiple myeloma: a study of the chronic malignancies working party of EBMT Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis Cryo-EM reveals structural breaks in a patientderived amyloid fibril from systemic AL amyloidosis Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril Lokale und systemische Leichtkettenamyloidosen bei Patienten mit rheumatologischen Erkrankungen Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis AL amyloidosis with a localized B cell neoplasia A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis Deferred autologous stem cell transplantation in systemic AL amyloidosis Systemic immunoglobulin light chain amyloidosis Local vs. systemic pulmonary amyloidosis—impact on diagnostics and clinical management The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis Incremental value of cardiac magnetic resonance for the evaluation of cardiac tumors in adults: experience of a high volume tertiary cardiology centre Ursachen und Therapie der systemischen AA-Amyloidose Funktionelle Analyse dominant negativer Mutanten der onkogenen Rezeptortyrosinkinase Xmrk von Yiphophorus

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Stefan Schönland (1969-)

Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis

Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries

In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

Biological and clinical impact of the immunoglobulin light chain sequence diversity in patients with dominant heart AL amyloidosis

In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis

First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma

High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders

Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT

Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients over 60 years of age: a prospective phase II study

Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis

Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group

P957: Carfilzomib, lenalidomide, dexamethasone followed by a second auto-HCT is an effective strategy in first relapse multiple myeloma: a study of the chronic malignancies working party of EBMT

Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis

Cryo-EM reveals structural breaks in a patientderived amyloid fibril from systemic AL amyloidosis

Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM

Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril

Lokale und systemische Leichtkettenamyloidosen bei Patienten mit rheumatologischen Erkrankungen

Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril

A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis

Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning

Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis

Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?

Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis

AL amyloidosis with a localized B cell neoplasia

A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis

Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis

Deferred autologous stem cell transplantation in systemic AL amyloidosis

Systemic immunoglobulin light chain amyloidosis

Local vs. systemic pulmonary amyloidosis—impact on diagnostics and clinical management

The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience

Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis

Incremental value of cardiac magnetic resonance for the evaluation of cardiac tumors in adults: experience of a high volume tertiary cardiology centre

Ursachen und Therapie der systemischen AA-Amyloidose

Funktionelle Analyse dominant negativer Mutanten der onkogenen Rezeptortyrosinkinase Xmrk von Yiphophorus